Harnessing γδ T cells in anticancer immunotherapy - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Trends in Immunology Année : 2012

Harnessing γδ T cells in anticancer immunotherapy

Résumé

γδ T lymphocytes are involved in the stress response to injured epithelia and in tissue homeostasis by limiting the dissemination of malignant or infected cells and by regulating the nature of the subsequent adaptive immune response. γδ T cells have potent MHC-unrestricted cytotoxicity, a high potential for cytokine release and broad-spectrum recognition of cancer cells, and as such, are attractive effectors for cancer immunotherapy. Current expectations are going beyond ex vivo manipulation of the Vγ9Vδ2 T subset, and target novel γδ T cell subsets, properties or receptors, to harness these unconventional T lymphocytes against cancer. This Opinion article discusses novel aspects of γδ T cell function during the course of anticancer therapies, as well as new avenues for their clinical implementation.
Fichier principal
Vignette du fichier
2012 - Hannani - Trends Immunol.pdf (939.61 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02047418 , version 1 (17-12-2020)

Identifiants

Citer

Dalil Hannani, Yuting Ma, Takahiro Yamazaki, Julie Dechanet-Merville, Guido Kroemer, et al.. Harnessing γδ T cells in anticancer immunotherapy. Trends in Immunology, 2012, 33 (5), pp.199-206. ⟨10.1016/j.it.2012.01.006⟩. ⟨hal-02047418⟩
28 Consultations
225 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More